hVIVO is the new name of Retroscreen Virology! (from 15 April 2015). hVIVO is a rapidly growing UK life sciences company pioneering a technology platform which uses human challenge models of disease involving healthy volunteers to study new drugs and investigate disease in a safe, controlled, clinical environment. Our belief is that the best way to understand human disease is by studying it in humans, not laboratory models.
Tuesday 1 September 2015
Respiratory syncytial virus, an ongoing medical dilemma: an expert commentary on respiratory syncytial virus prophylactic and therapeutic pharmaceuticals currently in clinical trials
Respiratory syncytial virus, an ongoing medical dilemma: an expert commentary on respiratory syncytial virus prophylactic and therapeutic pharmaceuticals currently in clinical trials
INFLUENZA AND OTHER RESPIRATORY VIRUSES | 9 JUNE 2015
http://pulse.me/s/4wVLC2
As the most important viral cause of severe respiratory disease in infants and increasing recognition as important in the ... Read more
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment